ALLMedicine™ Hypopituitarism Center
Research & Reviews 824 results
https://doi.org/10.1093/jnen/nlac046
Journal of Neuropathology and Experimental Neurology; Newell C, Kline GA et. al.
Jun 26th, 2022 - The Curious Case of Hypopituitarism.|2022|Newell C,Kline GA,Joseph JT,|
https://doi.org/10.1007/s11102-022-01239-7 10.1016/0002-9343(52)90027-2 10.1007/s11102-014-0567-8 10.3171/2017.5.JNS162901 10.1046/j.1365-2265.2001.01261.x 10.1210/jc.2012-3604 10.3171/jns.2006.104.1.7 10.1210/jc.2003-031908 10.1038/nrendo.2011.12 10.1007/s00701-017-3140-1 10.1007/s00701-021-04830-2 10.1111/j.1365-2265.2011.04279.x 10.1210/jc.2003-032180 10.1136/bmj.n71 10.3389/fendo.2019.00740 10.4158/EP-2020-0177 10.1210/jc.2007-0208 10.3171/jns.1998.89.6.0927 10.1016/j.wneu.2011.06.033 10.3171/foc.2007.23.3.4 10.1016/j.beem.2021.101485 10.1210/jcem.84.2.5465 10.7326/0003-4819-109-6-487 10.1210/jcem.81.7.8675592 10.1210/jcem-50-2-348 10.1210/jc.2007-2013 10.3171/2017.3.JNS163122 10.1210/jc.2004-1778 10.1111/j.1365-2265.2009.03723.x 10.1210/jc.2002-021438 10.3171/2020.3.FOCUS2084 10.1210/jc.2002-020374 10.1210/clinem/dgab012 10.3171/foc.2007.23.3.7 10.1210/jcem.80.11.7593411 10.1177/014107688507800404 10.1210/jcem.86.4.7399 10.1210/jc.2006-1328 10.1210/jcem.79.3.8077377 10.3171/jns.2005.102.4.0678 10.3171/2020.3.FOCUS2067
Pituitary Yang AB, Henderson F et. al.
Jun 18th, 2022 - Several surgical strategies have been proposed to treat MRI-negative Cushing's Disease. These include tumor removal, if identified, and if a tumor is not identified, resection of varying degrees of the pituitary gland, often guided by inferior pet...
https://doi.org/10.1097/MD.0000000000029274
Medicine Hsu CC, Lin HD et. al.
Jun 7th, 2022 - Pituitary apoplexy occurs in about 8% of those with nonfunctioning pituitary adenoma. Subsequent hormone deficiency, especially corticotropic deficiency, is the most common finding. We describe the unusual manifestations of adrenal insufficiency t...
https://clinicaltrials.gov/ct2/show/NCT05403255
Jun 3rd, 2022 - Objectives: Describe the quality of life and psychosocial repercussions of the disease in children 10-17 years of age with multiple pituitary hormone deficiency (either acquired or congenital), or isolated pituitary hormone deficiency (other than ...
https://doi.org/10.1136/bcr-2022-250637
BMJ Case Reports; Tellez R, Bromfield B et. al.
Jun 2nd, 2022 - Immunoglobulin G4-related disease (IgG4-RD) is a rare fibroinflammatory immune-mediated condition which can affect multiple organ systems and form mass-like lesions. Initial presentation can mimic other diseases such as pancreatic malignancy when ...
Guidelines 5 results
https://doi.org/10.1507/endocrj.EJ19-0163
Endocrine Journal; Arima H, Iwama S et. al.
Jun 28th, 2019 - Immune checkpoint inhibitors (ICIs) have become a promising treatment for advanced malignancies. However, these drugs can induce immune-related adverse events (irAEs) in several organs, including skin, gastrointestinal tract, liver, muscle, nerve,...
https://doi.org/10.1210/jc.2016-2118
The Journal of Clinical Endocrinology and Metabolism; Fleseriu M, Hashim IA et. al.
Nov 5th, 2016 - To formulate clinical practice guidelines for hormonal replacement in hypopituitarism in adults. The participants include an Endocrine Society-appointed Task Force of six experts, a methodologist, and a medical writer. The American Association for...
https://doi.org/10.1227/NEU.0000000000001387
Neurosurgery Fleseriu M, Bodach ME et. al.
Sep 17th, 2016 - Nonfunctioning pituitary adenomas (NFPAs) are among the most common pituitary lesions and may present with hypopituitarism and/or hyperprolactinemia. To review the existing literature as it pertains to preoperative endocrine assessment in the work...
https://doi.org/10.1227/NEU.0000000000001389
Neurosurgery Lucas JW, Bodach ME et. al.
Sep 17th, 2016 - Nonfunctioning pituitary adenomas (NFPAs) are among the most common pituitary lesions and may present clinically with vision loss and hypopituitarism. To characterize the existing literature as it pertains to the initial management of NFPAs. A sys...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5393422
The Journal of Clinical Endocrinology and Metabolism; Freda PU, Beckers AM et. al.
Apr 9th, 2011 - The aim was to formulate practice guidelines for endocrine evaluation and treatment of pituitary incidentalomas. Consensus was guided by systematic reviews of evidence and discussions through a series of conference calls and e-mails and one in-per...
Drugs 1 results see all →
Clinicaltrials.gov 32 results
https://clinicaltrials.gov/ct2/show/NCT05403255
Jun 3rd, 2022 - Objectives: Describe the quality of life and psychosocial repercussions of the disease in children 10-17 years of age with multiple pituitary hormone deficiency (either acquired or congenital), or isolated pituitary hormone deficiency (other than ...
https://clinicaltrials.gov/ct2/show/NCT02720952
May 4th, 2022 - This is a Phase 3, open label, single centre study of Infacort® in neonates, infants and children less than 6 years of age with adrenal insufficiency. The study will be conducted in a total of 24 subjects, before their 6th birthday, requiring repl...
https://clinicaltrials.gov/ct2/show/NCT04648137
Apr 13th, 2022 - Disruption of the hypothalamic-pituitary axis due to congenital abnormalities, tumors or head trauma may cause anterior and/or posterior pituitary deficiency also known as partial or panhypopituitarism. Patients with hypopituitarism, especially th...
https://clinicaltrials.gov/ct2/show/NCT05319301
Apr 8th, 2022 - Oxytocin (OT) is a hypothalamic peptide that enters the peripheral circulation via the posterior pituitary gland. OT plays a key role in regulating appetite, psychopathology, prosocial behavior and sexual function. Hypopituitarism is associated wi...
https://clinicaltrials.gov/ct2/show/NCT05206149
Jan 25th, 2022 - The diagnosis of secondary hypoadrenalism and GH deficiency (GHD) often requires the performance of a dynamic test. The glucagon stimulation test (GST) is one of the options for evaluating hypothalamic-pituitary function, representing a stimulus f...
News 49 results
https://www.onclive.com/view/multidisciplinary-care-for-malignant-melanoma
Apr 2nd, 2021 - For High-Definition, Click The treatment of patients with metastatic melanoma requires a team approach. The complexities of this disease warrants impute from several specialists to properly deliver care, the panelists agree. Along these lines, h...
https://www.onclive.com/view/i-o-second-line-treatment
Apr 2nd, 2021 - Peter Galle, MD: What do we have as evidence? The only I/O agent that has been convincing in demonstrating benefit was atezolizumab in combination with bevacizumab in first line. That’s what we have. The monotherapy has not made it into a signific...
https://www.onclive.com/view/fda-approves-two-new-indications-for-pembrolizumab-in-advanced-melanoma
Dec 4th, 2020 - Roger M. Perlmutter, MD, PhD The FDA has expanded the approval for single-agent pembrolizumab (Keytruda) to include the frontline treatment of patients with advanced melanoma regardless of BRAF status, based on a substantial improvement in progre...
https://reference.medscape.com/viewarticle/875763_6
Sep 16th, 2020 - Answer 5/5 Which of the following is accurate regarding treatment of acromegaly? Your peers chose: Pharmacologic therapy is the first-line treatment for acromegaly 0% Radiation therapy is routinely indicated for most patients with acromegaly 0% Fo...
https://www.medpagetoday.com/endocrinology/generalendocrinology/85879
Apr 9th, 2020 - In response to the COVID-19 pandemic, endocrinologists should take certain precautions with patients they commonly treat, according to new guidance from editors of The Journal of Clinical Endocrinology & Metabolism. Editor-in-Chief Paul Stewart, M...